Clinical Trials in Ohio

Showing 14861-14880 of 20,938 trials

Weightbearing Assessment of Tarsal Instability

NCT01868789

The purpose of this study is to compare the average joint motion and joint axis orientation of the hindfoot bones between patients diagnosed with adult-acquired flatfoot disorder (AAFD) and a control group of patients without foot deformity, using weight-bearing CT technology.

Adult-acquired Flatfoot Disorder (AAFD)

Orthopedic Foot and Ankle Center, Ohio23 participantsStarted May 2013

Westerville, Ohio, United States

COMPLETEDPhase 132 miles

A Pilot Study Investigating the Clinical Use of Tissue Engineered Vascular Grafts in Congenital Heart Surgery

NCT01034007

An initial feasibility and safety study evaluating the use of autologous tissue engineered vascular grafts as extra cardiac total cavopulmonary connection (EC TCPC) conduits in children with single ventricle anomalies.

Single Ventricle Cardiac Anomaly

Christopher Breuer4 participantsStarted Dec 2009

Columbus, Ohio, United States

COMPLETEDPhase 132 miles

Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine

NCT01092611

The purpose of this long-term follow-up study is to assess the long-term health status of HIV-infected subjects who previously participated in GSK-sponsored trials evaluating the investigational HIV vaccine 732462. This study will provide additional data concerning the long-term benefits/risks associated with vaccination. No vaccine will be administered during the study period. Vaccines were administered during the primary studies.

AIDS

GlaxoSmithKline190 participantsStarted Mar 2010

Bakersfield, California, United States • Fort Lauderdale, Florida, United States • Orlando, Florida, United States +38 more locations

Weightbearing Assessment of Tarsal Instability

A Pilot Study Investigating the Clinical Use of Tissue Engineered Vascular Grafts in Congenital Heart Surgery

Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine

Find Trials by Condition in Ohio

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

Early Diagnosis of Pulmonary Nodules

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?

Third International Study on Mechanical Ventilation

Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy

Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments

A Study Evaluating MM-310 in Patients With Solid Tumors

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

The Captivator EMR Registry

Investigating the Effect of Vortioxetine in Adult ADHD Patients

A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer

An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective

Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous Docetaxel